Silent Atrial Fibrillation in Patients With Mitral Stenosis and Sinus Rhythm and Its Correlation Left Atrial Thrombus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03505073|
Recruitment Status : Not yet recruiting
First Posted : April 23, 2018
Last Update Posted : April 23, 2018
Information provided by (Responsible Party):
Eman Sabry, Assiut University
Detection of Prevalence of silent atrial fibrillation in patients with Mitral stenosis and sinus rhythm and its correlation with the presence of left atrial thrombus.
|Condition or disease||Intervention/treatment|
|Atrial Fibrillation Left Atrial Thrombosis Mitral Valve Stenosis||Device: 12 lead electrocardiogram Device: Holter Monitor Device: Transthoracic echocardiogram Device: Transesophageal echocardiogram|
Show detailed description
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||214 participants|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Prevalence of Silent Atrial Fibrillation in Patients With Mitral Stenosis and Sinus Rhythm and Its Correlation With the Presence of Left Atrial Thrombus|
|Estimated Study Start Date :||May 2018|
|Estimated Primary Completion Date :||May 2019|
|Estimated Study Completion Date :||May 2019|
- Device: 12 lead electrocardiogram
A device recording the electrical activity of the heart over a period of time using electrodes placed on the skin.
- Device: Holter Monitor
A type of ambulatory electrocardiography device, a portable device for cardiac monitoring (the monitoring of the electrical activity of the cardiovascular system) for at least 24 to 48 hours (often for two weeks at a time).
- Device: Transthoracic echocardiogram
A standard echocardiogram or cardiac ultrasound in which the echocardiography transducer (or probe) is placed on the chest wall (or thorax) of the subject, and images are taken through the chest wall. This is a noninvasive, highly accurate, and quick assessment of the overall health of the heart.
- Device: Transesophageal echocardiogram
An alternative way to perform an echocardiogram. A specialized probe containing an ultrasound transducer at its tip is passed into the patient's esophagus. This allows image and Doppler evaluation from a location directly behind the heart.
Primary Outcome Measures :
- Detection of prevalence of silent atrial fibrillation in patients with Mitral stenosis and sinus rhythm and its correlation with the presence of left atrial thrombus. [ Time Frame: 1 Year ]Detection of prevalence of silent atrial fibrillation in patients with Mitral stenosis and sinus rhythm and its correlation with the presence of left atrial thrombus.
No Contacts or Locations Provided